GB (Global Blue Group Holding AG)
Insider Trading Activity
Every open-market purchase and sale reported by GB officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2016-03-10 | THOMAS J HOOK | President & CEO | A | — | — |
| 2016-01-25 | MICHAEL DINKINS | Exe VP Chief Financial Officer | MIXED | — | — |
| 2016-01-25 | Andrew P Holman | EVP, Global Sales & Marketing | MIXED | — | — |
| 2016-01-19 | THOMAS J MAZZA | VP, Corporate Controller | MIXED | — | — |
| 2016-01-19 | Andrew P Holman | EVP, Global Sales & Marketing | MIXED | — | — |
| 2016-01-19 | MICHAEL DINKINS | Exe VP Chief Financial Officer | MIXED | — | — |
| 2016-01-19 | Mauricio Arellano | EVP, Global Operations | MIXED | — | — |
| 2016-01-19 | Timothy G McEvoy | Sr. VP, Gen. Counsel & Sec. | MIXED | — | — |
| 2016-01-19 | Jose Antonio Gonzalez | President, CRM & Neuro | MIXED | — | — |
| 2016-01-19 | Jennifer M Bolt | President, Electrochem | MIXED | — | — |
| 2016-01-19 | THOMAS J HOOK | President & CEO | MIXED | — | — |
| 2016-01-11 | Declan Smyth | Pres., Advanced Surgical, Orth | A | — | — |
| 2016-01-06 | BILL R SANFORD | Director | A | — | — |
| 2016-01-05 | Kristin Trecker | Chief Human Resource Officer | A | — | — |
| 2016-01-05 | MICHAEL DINKINS | Exe VP Chief Financial Officer | A | — | — |
| 2016-01-05 | Jose Antonio Gonzalez | President, CRM & Neuro | A | — | — |
| 2016-01-05 | Joseph W Dziedzic | Director | A | — | — |
| 2016-01-05 | PAMELA G BAILEY | Director | A | — | — |
| 2016-01-05 | THOMAS J HOOK | President & CEO | MIXED | — | — |
| 2016-01-05 | Jean M. Hobby | Director | A | — | — |
| 2016-01-05 | MARTIN C MAXWELL | Director | A | — | — |
| 2016-01-05 | THOMAS J HOOK | President & CEO | A | — | — |
| 2016-01-05 | Timothy G McEvoy | Sr. VP, Gen. Counsel & Sec. | A | — | — |
| 2016-01-05 | Mauricio Arellano | EVP, Global Operations | A | — | — |
| 2016-01-05 | THOMAS J MAZZA | VP, Corporate Controller | A | — | — |
| 2016-01-05 | PETER H SODERBERG | Director | A | — | — |
| 2016-01-05 | Andrew P Holman | EVP, Global Sales & Marketing | MIXED | — | — |
| 2016-01-05 | Mauricio Arellano | EVP, Global Operations | MIXED | — | — |
| 2016-01-05 | JOSEPH A MILLER | Director | A | — | — |
| 2016-01-05 | Declan Smyth | Pres., Advanced Surgical, Orth | A | — | — |
| 2016-01-05 | THOMAS J MAZZA | VP, Corporate Controller | MIXED | — | — |
| 2016-01-05 | Jennifer M Bolt | President, Electrochem | MIXED | — | — |
| 2016-01-05 | Anthony P III Bihl | Director | A | — | — |
| 2016-01-05 | FILIPPO PASSERINI | Director | A | — | — |
| 2016-01-05 | Jennifer M Bolt | President, Electrochem | A | — | — |
| 2016-01-05 | Jose Antonio Gonzalez | President, CRM & Neuro | MIXED | — | — |
| 2016-01-05 | WILLIAM B JR SUMMERS | Director | A | — | — |
| 2015-12-16 | Kristin Trecker | Chief Human Resource Officer | A | — | — |
| 2015-12-07 | JOSEPH A MILLER | Director | MIXED | — | — |
| 2015-12-04 | BILL R SANFORD | Director | MIXED | — | — |
| 2015-11-25 | WILLIAM B JR SUMMERS | Director | MIXED | — | — |
| 2015-11-25 | PETER H SODERBERG | Director | MIXED | — | — |
| 2015-11-25 | Jennifer M Bolt | President, Electrochem | Sell | — | — |
| 2015-11-23 | PAMELA G BAILEY | Director | M | — | — |
| 2015-08-04 | THOMAS J HOOK | President & CEO | MIXED | — | — |
| 2015-07-07 | MARTIN C MAXWELL | Director | A | — | — |
| 2015-07-07 | FILIPPO PASSERINI | Director | A | — | — |
| 2015-07-07 | Jean M. Hobby | Director | A | — | — |
| 2015-07-07 | THOMAS J HOOK | President & CEO | MIXED | — | — |
| 2015-06-03 | THOMAS J HOOK | President & CEO | MIXED | — | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the GB quote page; the site-wide leaderboard is on the insider transactions hub.